Swiss Cancer Institute

We track 2 ClinicalTrials.gov studies led by Swiss Cancer Institute. The portfolio skews toward Phase 2 (1 trials).

2 clinical trials sponsored by Swiss Cancer Institute.

Pipeline by Phase

PhaseTrialsDistribution
Phase 2 1
50%
N/A 1
50%

Trial Status Breakdown

Trials by Swiss Cancer Institute

Reduced-dose Carboplatin-doublet-chemotherapy + Cemiplimab vs Cemiplimab Monotherapy in Treatment Naive Older and Frail Patients With Metastatic NSCLC With PD-L1 <50% A Multicentre Randomized Open-label Phase II Trial

NCT07020065 · RECRUITING · Phase 2

Phase III Randomized Controlled Trial Comparing Maintenance Systemic Therapy Alone With Systemic Therapy Plus Local Ablative Treatment for Patients With Advanced Stage IV Non-small Cell Lung Cancer

NCT06114108 · RECRUITING · N/A

Frequently Asked Questions

How many clinical trials does Swiss Cancer Institute sponsor?

Swiss Cancer Institute currently sponsors 2 clinical trials tracked on ReadTheTrial. These span Phase 2, N/A.

What conditions does Swiss Cancer Institute research?

Swiss Cancer Institute conducts research across multiple therapeutic areas. Browse the trial listings for details.

Is Swiss Cancer Institute recruiting for clinical trials?

Yes, Swiss Cancer Institute currently has 2 trials that are actively recruiting participants. Check individual trial pages for eligibility criteria and locations.

Explore More